45 related articles for article (PubMed ID: 1314004)
1. [Results of detection of hepatitis C virus antibodies (anti-HCV) in blood donors and selected patients].
Nováková J; Pokorná G; Hrubisko M
Vnitr Lek; 1992 Jan; 38(1):45-8. PubMed ID: 1314004
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
[TBL] [Abstract][Full Text] [Related]
4. [ALAT and viral RNA as risk factors in 68 blood donors with anti-hepatitis C antibodies].
Tullen E; De Saussure P; Soulier-Lauper M
Schweiz Med Wochenschr; 1993 Jan; 123(3):57-61. PubMed ID: 7678939
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C antibodies (anti-HCV) in blood donors at the transfusion department in Brno].
Klofera M; Chalupa P; Jezek P
Cas Lek Cesk; 1994 Aug; 133(15):459-62. PubMed ID: 7521789
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of anti-HCV positivity in patients undergoing haemodialysis or with malignant disease.
Paydas S; Aksu HS; Paydas S; Burgut R; Sagliker Y
Br J Clin Pract; 1994; 48(1):25-6. PubMed ID: 8179977
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
Abb J
Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
[TBL] [Abstract][Full Text] [Related]
9. [Anti-HCV positivity in blood donors].
Ehrmann J; Záková A; Krc I
Vnitr Lek; 1995 Apr; 41(4):227-9. PubMed ID: 7539194
[TBL] [Abstract][Full Text] [Related]
10. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
[TBL] [Abstract][Full Text] [Related]
11. [Reactivity of hepatitis C virus (HCV) antibody among blood donors in Hungary].
Héjjas M; Medgyesi G; Hajnal A
Orv Hetil; 1992 Jul; 133 Suppl 1():21-4. PubMed ID: 1321394
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
Kuperan P; Choon AT; Ding SH; Lee G
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
14. [HCV antibodies in selected patient groups and blood donors].
Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibody to hepatitis C virus in blood donors, high-risk groups and patients with liver diseases in Hungary. A multicentre study using ABBOTT EIA test and a comparison with an ORTHO ELISA test system.
Pár A; Kántor I; Barcsay E; Hollós I; Mezey I; Brojnás J; Takács M; Héjjas M; Illés M; Szontágh L
Acta Med Hung; 1991; 48(3-4):167-76. PubMed ID: 1726611
[TBL] [Abstract][Full Text] [Related]
16. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
17. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
18. [Investigation of anti-hepatitis C virus in the sera of different populations of Beijing].
Zhonghua Yi Xue Za Zhi; 1992 Jan; 72(1):18-20, 62-3. PubMed ID: 1374286
[TBL] [Abstract][Full Text] [Related]
19. Anti-hepatitis C virus antibodies and hepatitis C virus viraemia in haemodialysis patients.
Picciotto A; Varagona G; Gurreri G; Fiorini F; Sofia A; Coviello DA; Bonanni P; Icardi GC; Valle F; Celle G
Nephrol Dial Transplant; 1993; 8(10):1115-7. PubMed ID: 8272226
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of screening and complementary tests for anti-HCV antibodies].
Głoskowska-Moraczewska Z; Kacperska E; Seyfried H
Acta Haematol Pol; 1993; 24(3):273-80. PubMed ID: 7504386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
